Freedom Capital Markets Maintains Buy on Nutex Health, Raises Price Target to $306
Freedom Capital Markets analyst Gene Mannheimer maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $280 to $306.
Stocks · News reference
Nutex Health shares are trading higher after Freedom Capital Markets raised its price target on the stock from $280 to $306.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Reported Earlier, Nutex Health Approved For Dual Listing On Nasdaq Texas, Trading Set To Commence September 23, 2026
Nutex Health Q2 2026 Earnings Call: Complete Transcript
Nutex Health (NASDAQ:NUTX) released second-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to